Publications by authors named "Luis A Acaba-Berrocal"
Purpose: To compare the types and dosages of anti-vascular endothelial growth factors (VEGFs) to ascertain whether specific dosages or types of injection were associated with retreatment in clinical practice in the United States.
Design: Multicenter, retrospective, consecutive series.
Participants: Patients with retinopathy of prematurity (ROP) treated with anti-VEGF injections from 2007 to 2021.
Importance: Literature and anecdotal evidence suggest a relationship between male sex and retinopathy of prematurity (ROP). It is not known whether a difference, if present, is sex-related pathophysiologic predisposition or sex difference in meeting ROP screening criteria.
Objective: To evaluate the association of sex with the development of treatment-warranted ROP.
Purpose: To report practice patterns of intravitreal injections of anti-VEGF for retinopathy of prematurity (ROP) and outcomes data with a focus on retreatments and complications.
Design: Multicenter, international, retrospective, consecutive series.
Subjects: Patients with ROP treated with anti-VEGF injections from 2007 to 2021.
Purpose: To describe the clinical and imaging characteristics, pathologic features, and management options of retinal pigment epithelium (RPE) adenoma/adenocarcinoma.
Design: Retrospective case series.
Participants: Fifty-one patients with RPE adenoma/adenocarcinoma.
Purpose: To evaluate clinical features and survival outcomes of uveal metastasis based on patient age.
Methods: Retrospective analysis of all patients with uveal metastasis evaluated on the Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA, USA between February 1, 1974 and June 1, 2017. The features and outcomes were analyzed based on patient age classified as children (0-20 years), young adults (21-40 years), middle [aged] adults (41-60 years), older adults (61-80 years) and senior adults (81-100 years).
Purpose: To evaluate interval between primary cancer diagnosis and uveal metastasis and assess survival outcomes based on whether the primary cancer was diagnosed before or after uveal metastasis.
Methods: In this retrospective analysis, all patients with uveal metastasis evaluated on the Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA, USA between February 1, 1974 and June 1, 2017 were included. Features and outcomes based on timing of primary cancer diagnosis, whether before or after diagnosis of uveal metastasis, were assessed.
Background: Lacking in previous studies on uveal metastasis is a robust statistical comparison of patient demographics, tumor features, and overall survival based on patient sex.
Objective: The aim of this study was to evaluate demographics, clinical features, and overall survival of patients with uveal metastasis based on sex.
Method: This is a retrospective analysis.
Purpose: To investigate demographics and clinical features of patients with amelanotic choroidal tumours.
Design: Retrospective analysis.
Methods: Comparison of demographic and clinical features of various amelanotic choroidal tumours based on stratification by patient age, sex and tumour diameter.
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Middle East Afr J Ophthalmol
September 2018
Purpose: The purpose of this study is to evaluate patients with uveal metastasis based on primary tumor site.
Methods: Retrospective analysis from Wills Eye Hospital, Philadelphia, PA, USA, for uveal metastasis clinical features and outcomes based on the primary tumor site.
Results: There were 2214 uveal metastases diagnosed in 1111 consecutive patients.